Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 7, 2014; 20(25): 8195-8200
Published online Jul 7, 2014. doi: 10.3748/wjg.v20.i25.8195
Published online Jul 7, 2014. doi: 10.3748/wjg.v20.i25.8195
Table 1 Baseline hepatitis B surface antigen and hepatitis B virus DNA levels in 55 patients
| Baseline HBsAg (IU/mL) | Baseline HBV DNA (log10) | Case number (constituent ratio, %) |
| > 20000 | 8.14 ± 0.87 | 18 (32.7) |
| 1500-20000 | 7.39 ± 1.01 | 26 (47.3) |
| < 1500 | 5.89 ± 1.07 | 11 (20.0) |
Table 2 Baseline hepatitis B surface antigen levels and virological response rates after 48 wk of Pegylated interferon-α2b therapy
| Baseline HBsAg (IU/mL) | Virological response rate (%) |
| > 20000 | 3/18 (16.7) |
| 1500-20000 | 11/26 (42.3) |
| < 1500 | 7/11 (63.6) |
- Citation: Chen GY, Zhu MF, Zheng DL, Bao YT, Wang J, Zhou X, Lou GQ. Baseline HBsAg predicts response to pegylated interferon-α2b in HBeAg-positive chronic hepatitis B patients. World J Gastroenterol 2014; 20(25): 8195-8200
- URL: https://www.wjgnet.com/1007-9327/full/v20/i25/8195.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i25.8195